UPDATE 2-Allergan jumps as FDA hints Botox migraine support By: Reuters: Company News August 02, 2010 at 11:12 AM EDT * Says FDA seeks info on Botox anti-migraine risk strategy Read More >> Related Stocks: Merck & Co